drugset / Trial / NCT00056472

Study of Pharmacotherapy of Psychotic Depression

NCT00056472

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will determine the effectiveness of combining selective serotonin reuptake inhibitors (SSRIs) with antipsychotic medications in the treatment of psychotic depression.

Timeline

Start
2003-01
Primary completion
2008-06
Completion
2008-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sertraline Small molecule 150 mg
Comparator Sertraline Small molecule 200 mg
Comparator Olanzapine Small molecule 10 mg
Comparator Olanzapine Small molecule 20 mg